Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

NCT00595309 ·Status: COMPLETED ·Phase: PHASE3

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

NCT00595270 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

NCT00776230 ·Status: COMPLETED ·Phase: PHASE3

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

NCT00596271 ·Status: COMPLETED ·Phase: PHASE3

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

NCT01559831 ·Status: WITHDRAWN ·Phase: PHASE1

Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

NCT01954810 ·Status: UNKNOWN ·Phase: PHASE4

Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis

NCT06825312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

NCT00621764 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

NCT02602652 ·Status: COMPLETED ·Phase: NA

Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

NCT00412516 ·Status: COMPLETED ·Phase: PHASE3

Purified Inactivated Japanese Encephalitis Vaccine

NCT04223037 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers

NCT01092507 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

NCT04648241 ·Status: COMPLETED ·Phase: PHASE3

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

NCT01246479 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants

NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

NCT01396512 ·Status: COMPLETED ·Phase: PHASE3

Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers

NCT01001988 ·Status: COMPLETED ·Phase: PHASE3

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

NCT04817917 ·Status: UNKNOWN ·Phase: PHASE4

Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries

NCT01047839 ·Status: COMPLETED ·Phase: PHASE3

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

NCT00735644 ·Status: COMPLETED ·Phase: PHASE3

Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

NCT06678373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

NCT01188343 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

NCT02880865 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

NCT02526550 ·Status: COMPLETED ·Phase: PHASE4

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

NCT00249769 ·Status: COMPLETED ·Phase: PHASE3